Hemokinin-1 has Substance P-like function in U-251 MG astrocytoma cells: A pharmacological and functional study

被引:45
作者
Berger, A [1 ]
Paige, CJ [1 ]
机构
[1] Univ Toronto, Dept Immunol, Princess Margaret Hosp, Ontario Canc Inst,Univ Hlth Network, Toronto, ON M5G 2M9, Canada
关键词
hemokinin-1; substance P; tachykinin; neurokinin receptor; astrocytoma; cytokine;
D O I
10.1016/j.jneuroim.2005.03.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Substance P (SP) triggers responses in astrocytoma cells, which are considered important for proliferation and neuroinununomodulatory activity. In this study, we compared the effects of SP with those of the novel tachykinin Hemokinin-1 (HK-1) in the human astrocytoma cell line U-251 MG. We show that U-251 MG cells express high levels of Neurokinin-1 (NK-1) receptors. The binding affinities of I-125-SP and I-125-mHK-1 to these receptors were in a similar, subnanomolar range. HK-1 and SP stimulated Ca2+ mobilization and induced increased cytokine mRNA expression. A specific NK-1 receptor antagonist blocked the observed effects. We conclude that there are no qualitative differences in SP and HK-1-evoked responses, suggesting that both peptides act through NK-1 receptors in U-251 MG cells. Moreover, we show TAC4 mRNA expression in gliomas, indicating a possible involvement of HK-1 in glioma biology. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:48 / 56
页数:9
相关论文
共 40 条
[1]   Pharmacological profile of the novel mammalian tachykinin, hemokinin 1 [J].
Bellucci, F ;
Carini, F ;
Catalani, C ;
Cucchi, P ;
Lecci, A ;
Meini, S ;
Patacchini, R ;
Quartara, L ;
Ricci, R ;
Tramontana, M ;
Giuliani, S ;
Maggi, CA .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (01) :266-274
[2]  
Bennett Vicki J., 2001, BMC Chemical Biology, V1, P1, DOI 10.1186/1472-6769-1-1
[3]   Galanin and galanin receptors in human gliomas [J].
Berger, A ;
Santic, R ;
Almer, D ;
Hauser-Kronberger, C ;
Huemer, M ;
Humpel, C ;
Stockhammer, G ;
Sperl, W ;
Kofler, B .
ACTA NEUROPATHOLOGICA, 2003, 105 (06) :555-560
[4]   HETEROGENEITY OF GENOTYPIC AND PHENOTYPIC CHARACTERISTICS OF 15 PERMANENT CELL-LINES DERIVED FROM HUMAN GLIOMAS [J].
BIGNER, DD ;
BIGNER, SH ;
PONTEN, J ;
WESTERMARK, B ;
MAHALEY, MS ;
RUOSLAHTI, E ;
HERSCHMAN, H ;
ENG, LF ;
WIKSTRAND, CJ .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1981, 40 (03) :201-229
[5]   Pharmacological profile of hemokinin 1: a novel member of the tachykinin family [J].
Camarda, V ;
Rizzi, A ;
Calo, G ;
Guerrini, R ;
Salvadori, S ;
Regoli, D .
LIFE SCIENCES, 2002, 71 (04) :363-370
[6]   Influence of gastrin on human astrocytic tumor cell proliferation [J].
Camby, I ;
Salmon, I ;
Danguy, A ;
Pasteels, JL ;
Brotchi, J ;
Martinez, J ;
Kiss, R .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (09) :594-600
[7]  
Cassoni P, 1998, INT J CANCER, V77, P695, DOI 10.1002/(SICI)1097-0215(19980831)77:5<695::AID-IJC6>3.3.CO
[8]  
2-Z
[9]   Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils [J].
Duffy, RA ;
Hedrick, JA ;
Randolph, G ;
Morgan, CA ;
Cohen-Williams, ME ;
Vassileva, G ;
Lachowicz, JE ;
Laverty, M ;
Maguire, M ;
Shan, LS ;
Gustafson, E ;
Varty, GB .
NEUROPHARMACOLOGY, 2003, 45 (02) :242-250
[10]   Tachykinins regulate the function of platelets [J].
Graham, GJ ;
Stevens, JM ;
Page, NM ;
Grant, AD ;
Brain, SD ;
Lowry, PJ ;
Gibbins, JM .
BLOOD, 2004, 104 (04) :1058-1065